Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Management
  • News

IMUNON Appoints Stacy R. Lindborg As President And CEO, Effective May 13, 2024

By Benzinga Newsdesk
May 8, 8:14 AM
Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experience in drug development and business strategyLAWRENCEVILLE, N.J., May 08, 2024 (GLOBE

IMNN

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
April 26, 4:31 PM
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 11.0% to $0.73 during Friday’s after-market session. The company’s market cap…

ACCD

Read More
2 minute read
  • News

IMUNON Reports Compliance With Nasdaq Listing Requirements

By Benzinga Newsdesk
April 11, 8:15 AM
IMUNON, Inc. (NASDAQ:IMNN) ("IMUNON" or the "Company"), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today announced that on April

IMNN

Read More
1 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights
April 5, 8:09 AM
Gainers Protara Therapeutics (NASDAQ:TARA) stock increased by 40.3% to $5.64 during Friday’s pre-market session. The market value of…

AIH

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights
April 2, 4:31 PM
Gainers OneMedNet (NASDAQ:ONMD) shares moved upwards by 75.9% to $1.39 during Tuesday’s after-market session. The market value of…

ACOR

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights
April 2, 8:07 AM
Gainers MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday’s pre-market session. The company’s market cap…

ACON

Read More
5 minute read
  • Earnings

Earnings Scheduled For March 28, 2024

By Benzinga Insights
March 28, 5:24 AM
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

ACHV

Read More
1 minute read
  • Earnings

Preview: Imunon’s Earnings

By Benzinga Insights
March 27, 1:01 PM
Imunon (NASDAQ:IMNN) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here’s what investors need…

IMNN

Read More
12 minute read
  • Earnings

Earnings Scheduled For November 14, 2023

By Benzinga Insights
November 14, 9:23 AM
Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.

ACXP

Read More
1 minute read
  • Earnings

Imunon’s Earnings Outlook

By Benzinga Insights
November 13, 11:01 AM
Imunon (NASDAQ:IMNN) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here’s what investors need…

IMNN

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service